Navigation Links
Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases
Date:6/29/2009

xcerpts from an interview with Dr. Kendall Lee describing the research, are available on the Mayo Clinic News Blog.

About Mayo Clinic

Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy that "the needs of the patient come first." More than 3,300 physicians, scientists and researchers and 46,000 allied health staff work at Mayo Clinic, which has sites in Rochester, Minn., Jacksonville, Fla., and Scottsdale/Phoenix, Ariz. Collectively, the three locations treat more than half a million people each year. To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. MayoClinic.com (www.mayoclinic.com) is available as a resource for your health stories. For more on Mayo Clinic research, go to www.mayo.edu.


'/>"/>
SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
2. Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
3. Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
4. West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial
5. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
6. DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
7. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
8. New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
9. ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps(TM)
10. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
11. HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... TARRYTOWN, N.Y., Dec. 4 Bayer Dia...inners of Bayer,s "Express Your Simple Win Creativ...elected the winning video entries submitted by chi...rand prize is an in-person meeting today with Nick...ke Nick, are: Caleb, age 6, from Danbury, CT, who ...
(Date:12/4/2009)...LMINGTON, Del., Dec. 4 A... US Food and Drug Administration (FDA) has approve...e) Extended Release Tablets as adjunctive (add-on)... Depressive Disorder (MDD). SEROQUEL XR is the onl...reat both major depressive disorder as adjunctive ...
(Date:12/3/2009)...CTON, Mass., Dec. 3 Alle...gs, Inc. (NYSE: HRC ), today announced the launc...ment Manufacturer) business website www.AllenAma...n Amatech(TM) brand identity and includes an onlin...d descriptions and design specifications for the p...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 1Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 2Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 3Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 4Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 5Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 6Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 7Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 8Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 9Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 10Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 11Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 12Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 13Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 14Iterative reconstruction technique significantly reduces patient radiation dose during CT scans 54816 1Nanomagnets guide stem cells to damaged tissue 13621 1
(Date:12/4/2009)...wswire-FirstCall/ -- Hill-Rom Holdings, Inc. (NYSE...arter dividend of $0.1025 per share. This dividend...December 3, 2009, and is payable on December 31, 2...2009. ,, ABOUT HILL-ROM HOLDINGS, INC. ,...and provider of medical technologies and related s...
(Date:12/4/2009)...swire-FirstCall/ -- MedClean Technologies, Inc. (O...ny has entered into a preferred stock purchase agr...limited liability company, doing business as Soci...he Purchase Agreement, MedClean will receive up to...d to sell up to 750 shares of its Series C Preferr...
(Date:12/4/2009)... Reform Bills Will Increase Deficit ,, WASHINGT...ms that the pending health reform bills aren,t rea...savings take effect, Congress has allowed the vast...past two decades to take effect and produce signif...et and Policy Priorities shows. ,, The analysis...
(Date:12/4/2009).../ -- The National Cancer Institute has awarded a $...inson Cancer Research Center to become the nation,...Contact Center. ,, The move will create 60 new ...e size of its current CIS workforce - once the con...heduled for March 15, 2010. The Seattle CIS center...
(Date:12/4/2009)...progress has been made over the last 15 years in t...treat epilepsy and its complications. Yet this pr... of the 50 million people around the world, includ... United States who have the disorder, , Accordin...merican Epilepsy Society (AES), there is an enormo...
Breaking Medicine News(10 mins):Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 2Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 3Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 4Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4
...s from the University of Pittsburgh School of Medi...h for an effective treatment for human liver canc...ics. Using a newly available monoclonal antib... According to the researchers, this finding has...
...es, if properly managed, could serve as important ...ty of Missouri-Columbia researcher has revealed . ...n the United States, and approximately 70 percent ...bitat for species native to the area. Golf courses...
...ricas biggest eye care companies has had its recen... approved by the Food and Drug Administration . ...n is the first Lasik device to correct one of a pa... all the nearsightedness to help distance vision ...
...which binds estrogen receptor alpha (ER-alpha), is...ver, one-third of new breast cancers lack detectab...are more aggressive and have a worse prognosis tha...ublication in the August print issue of the Journa...
...ransplant Week this year, in UK, is being taken ve...ecently aims to make aware the desperate need of o... the UK. The campaign has been launched to rai... In the UK every year, more than 600 patients...
...blished in the New England Journal of Medicine has... with folic acid . The extensive study whic...m Laval University in Quebec found that the rate o...086 percent afterward. The scientists were r...
Other Medicine News:Health News:A New Monoclonal Antibody Kills Cancer Cells 2Health News:Golf Courses Could Serve as Wildlife Sanctuaries If Managed Properly 2Health News:Food Fortification With Folic Acid Does The Trick 2
...ers the most comprehensive family of lightweight s...act incision, Glaucoma filtration, and Vitreoretin...eved with minimal tissue trauma and minimal periph... available in 18, 20, and 20-23Ga tapered designs....
...ers the most comprehensive family of lightweight s...act incision, Glaucoma filtration, and Vitreoretin...eved with minimal tissue trauma and minimal periph... available in 18, 20, and 20-23Ga tapered designs....
Lieberman Aspirating Speculum
Lieberman Speculum
Medicine Products: